TGFB1 and systemic sclerosis: In addition, co-incubation of healthy Treg cells with the plasma of SSc patients could reduce the expression of CD69 and TGF-β of Tregs by some unknown factors in the plasma, thus reducing the functional response of Treg cells to effector T cells (Radstake et al., 2009).